查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
上游生物加工市場規模和預測、全球和區域佔有率、趨勢和成長機會分析報告範圍：按產品類型、工作流程、使用類型、模式和地理位置
市場調查報告書
商品編碼
1424134

上游生物加工市場規模和預測、全球和區域佔有率、趨勢和成長機會分析報告範圍：按產品類型、工作流程、使用類型、模式和地理位置

Upstream Bioprocessing Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Workflow, Usage Type, Mode, and Geography
出版日期: | 出版商: The Insight Partners | 英文 210 Pages | 訂單完成後即時交付

價格

全球上游生物加工市場預計將從2022年的91.74億美元增加至2030年的250.46億美元。預計2022年至2030年該市場將以13.4%的CAGR成長。

推動上游生物加工市場成長的關鍵因素包括一次性生物反應器的商業化使用、生物製藥製造的外包以及製藥和生物技術行業的快速成長。然而，嚴格的監管框架阻礙了市場的成長。

上游生物加工市場的市場機會

上游生物加工市場正經歷一波技術進步浪潮，帶來了巨大的產業機會。這些進步包括細胞培養系統、生物反應器設計、製程監測和控制以及自動化和數位化整合的創新發展。 2023 年 9 月，Repligen 公司和 Sartorius 推出了整合生物反應器系統。 Repligen 的 XCell 交替切向流 (ATF) 上游強化技術已整合到 Sartorius Biostat 攪拌釜反應器 (STR) 中。此生物反應器技術旨在使生物製藥公司更容易應用氮氣灌注和強化種子培養。 Biostat STR 中整合了嵌入式 XCell ATF 硬體和軟體模組，該模組將整合製程分析技術與預先定義的高階控制配方相結合。該模組旨在簡化細胞生長的管理並增強灌注過程中的細胞保留，從而無需單獨的細胞保留控制塔。此類現代產品具有增強的製程效率、可擴展性和適應性，這對於滿足生物製藥生產不斷變化的需求至關重要。

先進的細胞培養基配方和下一代生物反應器技術有助於最佳化上游生物程序，從而提高產品產量、提高產品品質以及複雜生物製劑的高效生產。高階分析和即時製程監控的持續整合徹底改變了生物加工中數據驅動的決策，推動了精確度和製程最佳化的機會。生物技術的進步也促進了靈活和模組化製造平台的發展。此外，機器學習、人工智慧和預測分析的融合正在為預測性生物加工鋪平道路，釋放主動製程控制、品質保證和成本最佳化的機會。因此，上游生物加工的技術進步正在重塑該產業，為創新、效率和適應性提供了新的途徑。

阻礙上游生物加工市場的因素

美國食品藥物管理局和歐洲藥品管理局 (EMA) 等監管機構始終嚴格監控藥品製造商的營運。因此，這些企業必須遵守促進現行良好生產規範 (cGMP) 和良好實驗室規範 (GLP) 的最新法規，以確保對製造流程和設施的控制和監控。目前，FDA 的 CBER 法規並未提及一次性生物反應器。任何偏離本指南註冊方案、要求和要求的行為都可能導致製造商或外包組織策劃的臨床試驗終止。

使用 SUB 的最大問題是這些分子在臨床試驗中可能不會產生與在實驗室環境中產生的結果相同的結果。 SUB 的混合機制也可能導致難以遵守法規，從而限制了它們的使用。例如，在波浪式SUB中，混合原理僅限於搖擺運動，導致混合不均勻並產生錯誤。因此，生物製劑的安全性和有效性可能會在SUBs的應用中引起重大關注。因此，與生物技術產業相關的嚴格法規增加了對生物反應器的需求。此外，中國、印度和巴西等發展中國家缺乏監管框架阻礙了上游生物加工市場的成長。

上游生物加工市場：細分概述

根據產品類型，上游生物加工市場分為生物反應器和發酵槽、細胞培養基、過濾器、袋子和容器等。 2022 年，生物反應器/發酵槽領域在上游生物加工市場中佔據最大佔有率。此外，預計細胞培養領域在 2022 年至 2030 年期間將實現顯著的CAGR。生物反應器和發酵槽作為核心容器，細胞和微生物在其中生長，用於涉及生物衍生化合物的表達和生產的各種治療和生物加工應用。這些系統經過精心設計，旨在為細胞生長提供最佳環境，並結合對溫度、pH、溶解氧和攪拌等參數的精確控制。這些對於大規模生物加工操作中培養細胞和微生物至關重要。

根據工作流程，上游生物加工市場分為培養基製備、細胞培養和細胞分離。 2022 年，細胞分離領域在上游生物加工市場中佔據最大佔有率。進一步預計，2022 年至 2030 年將出現顯著的CAGR。細胞分離是從培養物中分離蛋白質產品（細胞）的初始階段。生物反應器中收集的產物的數量和質量將決定是否終止細胞培養，這是一個重要的決定。

根據使用類型，全球上游生物加工市場分為一次性和多用途。至2022年，一次性細分市場將佔據更大的市場佔有率。2022-2030年，該細分市場將在上游生物加工市場中錄得顯著的CAGR。隨著一次性技術的廣泛採用，上游生物加工市場經歷了一場變革。一次性系統，包括生物反應器、袋子和連接器，因其靈活性、成本效益和交叉污染風險降低而受到關注。這些一次性組件取代了傳統的不銹鋼設備，為生物生產提供了更靈活和可擴展的方法。一次性趨勢加速了製程開發，最大限度地減少了清潔和驗證工作，並促進了生產運行之間的快速轉換。

上游生物加工市場依模式分為內部和外包。 2022年，內部細分市場佔據了更大的市場佔有率。外包業務預計在 2022 年至 2030 年期間將錄得更高的CAGR。隨著生物製藥公司尋求對其生產流程的更大控制，內部製造在上游生物加工市場中越來越受歡迎。建立內部上游生物加工設施使公司能夠根據自己的需求客製化流程，確保採用更客製化和高效的方法。這項措施通常涉及對最先進的生物反應器、細胞培養系統和相關技術的投資。

上游生物加工市場：地理概況

2022年，北美佔據全球最大的上游生物加工市場。美國擁有該地區最大的上游生物加工市場佔有率，預計2022-2030年CAGR最高。美國是生物反應器最大的市場——美國的一些市場參與者為製藥和生物技術公司製造生物反應器。新生物反應器的推出、地理擴張策略以及市場參與者之間的合作夥伴關係促進了美國上游生物加工市場的成長。 2023 年 4 月，BioMADE 宣布了五個新項目，重點是解決美國在生物工業製造中生物反應器的研究和採用方面的差距。這些項目的資金承諾為 1050 萬美元，涵蓋工程、硬體開發和可擴展性，以解決加速經濟發展的障礙。這些項目將專注於創新，引入施密特期貨支援的先進生物反應器設計。 2023 年 4 月，Cytiva 推出了 X 平台生物反應器，以一次性產品簡化上游生物加工作業。最初，生物反應器有 50 L 和 200 L 兩種規格。 X-Platform生物反應器配備了Figurate自動化解決方案軟體，它們可以透過人體工學改進、生產能力和簡化供應鏈操作來提高製程效率。

生物製藥產業的成長主要得益於技術進步、靈活性提高和營運成本低廉，也有利於美國上游生物加工市場。根據國際貿易管理局（ITA）的數據，美國是最大的生物製藥市場，也是全球生物製藥研發的領導者。根據美國藥物研究與製造商協會（PhRMA）統計，美國企業佔全球藥品研發工作量的近50%，並成功開發出許多擁有智慧財產權的新藥。新生物製劑開發的不斷增加，導致更多新分子實體（NME）獲得監管機構的批准，為美國上游生物加工市場的成長創造了機會。根據《化學與工程新聞》報道，美國食品藥物管理局（FDA）在 2022 年、2021 年和 2020 年分別批准了約 37 個、50 個和 53 個新 NME。

此外，美國製藥和生物技術公司增加研發投資以改善臨床試驗結果並確保病患安全，有助於美國上游生物加工市場的成長。此外，隨著美國政府投資的增加，精準醫療的吸引力不斷增強，這可能會促進未來幾年的市場成長。

A few of the major primary and secondary sources referred to while preparing the report on the upstream bioprocessing market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (世界衛生組織).

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：上游生物加工市場格局

  • 概述
  • PEST分析

第 5 章：上游生物加工市場 - 主要市場動態

  • 上游生物加工市場 - 主要市場動態
  • 市場促進因素
    • 一次性生物反應器的商業用途
    • 生物製藥製造外包
    • 醫藥和生技產業快速成長
  • 市場限制
    • 嚴格的規範架構
  • 市場機會
    • 技術進步
  • 未來的趨勢
    • 加大生醫產業研發投入
  • 促進因素和限制的影響：

第 6 章：上游生物加工市場 - 全球市場分析

第 7 章：上游生物加工市場分析 - 按產品類型

  • 生物反應器/發酵罐
  • 細胞培養
  • 過濾器
  • 袋子和容器
  • 其他

第 8 章：上游生物加工市場分析 - 按工作流程

  • 媒體準備
  • 細胞培養
  • 細胞分離

第 9 章：上游生物加工市場分析 - 按使用類型

  • 一次使用
  • 多用途

第 10 章：上游生物加工市場分析 - 按模式

  • 內部
  • 外包

第 11 章：上游生物加工市場 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 12 章：產業格局

  • 概述
  • 上游生物加工市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 13 章：公司簡介

  • Thermo Fisher Scientific Inc
  • Esco Micro Pte Ltd
  • Cellexus International Ltd
  • Sartorius AG
  • Danaher Corp
  • Getinge AB
  • Merck KGaA
  • Corning Inc
  • Entegris Inc
  • PBS Biotech Inc

第 14 章：附錄

Product Code: TIPRE00006819

The global upstream bioprocessing market is expected to reach US$ 25.046 billion in 2030 from US$ 9.174 billion in 2022. The market is estimated to grow with a CAGR of 13.4% from 2022 to 2030.

Key factors driving the upstream bioprocessing market growth include the commercial use of single-use bioreactors, outsourcing of biopharmaceutical manufacturing, and rapid growth of pharmaceutical and biotechnology industries. However, a stringent regulatory framework hinders market growth.

Market Opportunities of Upstream Bioprocessing Market

The upstream bioprocessing market is experiencing a wave of technological advancements, presenting considerable industry opportunities. These advancements include innovative developments in cell culture systems, bioreactor design, process monitoring, and control, as well as the integration of automation and digitalization. In September 2023, Repligen Corporation and Sartorius introduced an integrated bioreactor system. Repligen's XCell Alternating Tangential Flow (ATF) upstream intensification technology has been integrated into the Sartorius Biostat stirred-tank reactor (STR). This bioreactor technology is designed to make the application of N perfusion and intensified seed train easier for biopharmaceutical firms. An embedded XCell ATF hardware and software module that combines integrated process analytical technologies with predefined advanced control recipes is incorporated into Biostat STR. This module is intended to simplify the management of cell growth and enhance cell retention in perfusion procedures, eliminating the need for a separate cell retention control tower. Such modern products feature enhanced process efficiency, scalability, and adaptability, which are crucial for meeting the evolving demands of biopharmaceutical production.

Advanced cell culture media formulations and next-generation bioreactor technologies are contributing to the optimization of upstream bioprocessing, enabling higher product yields, improved product quality, and the efficient production of complex biologics. The ongoing integration of advanced analytics and real-time process monitoring revolutionizes data-driven decision-making in bioprocessing, driving precision and process optimization opportunities. Progress in biotechnology also fosters the development of flexible and modular manufacturing platforms. Additionally, the convergence of machine learning, artificial intelligence, and predictive analytics is paving the way for predictive bioprocessing, unlocking proactive process control, quality assurance, and cost optimization opportunities. Thus, technological advancements in upstream bioprocessing are reshaping the industry, presenting new avenues for innovation, efficiency, and adaptability.

Factor Hampering Upstream Bioprocessing Market

Regulatory authorities such as the Food & Drug Administration and the European Medicine Agency (EMA) monitor the operations of pharmaceutical manufacturers with consistent stringency. These businesses are thus bound to abide by the updated regulations promoting current good manufacturing practices (cGMP) and good laboratory practices (GLP) for assuring the control and monitoring of manufacturing processes and facilities. Currently, the FDA's CBER regulations do not mention single-use bioreactors. Any diversions from the registered protocols, demands, and requirements of this guidance may lead to the termination of the clinical trials orchestrated by manufacturers or outsourced organizations.

The biggest concern with using SUBs is that the molecules may not generate the same results in clinical trials as they produce in laboratory environments. The mixing mechanisms of SUBs may also lead to difficulties adhering to regulations, which restricts their use. For instance, in wave-type SUBs, the mixing principle is limited to a rocking movement, leading to uneven mixing and causing errors. Hence, the safety and efficacy of biologics may raise significant concerns in the application of SUBs. Therefore, stringent regulations associated with the biotechnology industry bolster the demand for bioreactors. Moreover, the lack of regulatory framework in developing nations such as China, India, and Brazil hinders the upstream bioprocessing market growth.

Upstream Bioprocessing Market: Segmental Overview

Based on product type, the upstream bioprocessing market is segmented into bioreactors and fermenters, cell culture media, filters, bags and containers, and others. The bioreactors/fermenters segment held the largest share of the upstream bioprocessing market in 2022. Moreover, the cell culture segment is anticipated to register a significant CAGR during 2022-2030. Bioreactors and fermenters serve as core vessels in which cells and microorganisms are grown for various therapeutic and bioprocessing applications involving the expression and production of biologically derived compounds. These systems are engineered to provide an optimal environment for cell growth, incorporating precise control over parameters such as temperature, pH, dissolved oxygen, and agitation. These are critical for cultivating cells and microorganisms in large-scale bioprocessing operations.

Based on workflow, the upstream bioprocessing market is classified into media preparation, cell culture, and cell separation. The cell separation segment held the largest share of the upstream bioprocessing market in 2022. It is further anticipated that a significant CAGR will be registered from 2022 to 2030. Cell separation is the initial stage of segregating protein products (cells) from the culture. The amount and quality of the product collected in the bioreactors will determine whether to terminate the cell culture, which is an important decision.

Based on usage type, the global upstream bioprocessing market is classified into single use and multi-use. The single-use segment held a larger share of the market in 2022. The same segment will record a significant CAGR in the upstream bioprocessing market during 2022-2030. The upstream bioprocessing market has experienced a transformative shift with the widespread adoption of single-use technologies. Single-use systems, including bioreactors, bags, and connectors, have gained prominence for their flexibility, cost-effectiveness, and reduced risk of cross-contamination. These disposable components replace traditional stainless-steel equipment, offering a more agile and scalable approach to bioproduction. The single-use trend accelerates process development, minimizes cleaning and validation efforts, and facilitates quick changeovers between production runs.

The upstream bioprocessing market is segmented into in-house and outsourced based on mode. In 2022, the in-house segment held a larger market share. The outsourced segment is expected to record a higher CAGR during 2022-2030. In-house manufacturing is gaining traction in the upstream bioprocessing market as biopharmaceutical companies seek greater control over their production processes. Establishing in-house upstream bioprocessing facilities enables companies to tailor processes to their needs, ensuring a more customized and efficient approach. This move often involves investment in state-of-the-art bioreactors, cell culture systems, and associated technologies.

Upstream Bioprocessing Market: Geographical Overview

North America accounted for the largest global upstream bioprocessing market share in 2022. The US held the largest upstream bioprocessing market share in the region and is anticipated to register the highest CAGR during 2022-2030. The US is the largest market for bioreactors-several market players in the US manufacture bioreactors for pharmaceutical and biotechnology companies. Launch of new bioreactors, geographic expansion strategies, and partnerships among market players bolster the upstream bioprocessing market growth in the US. In April 2023, BioMADE announced five new projects focused on addressing gaps in the US' research and adoption of bioreactors in bio-industrial manufacturing. With a funding commitment of US$ 10.5 million, these projects would span engineering, hardware development, and scalability to address the barriers to accelerating an economy. These projects would focus on innovation to introduce advanced bioreactor designs supported by Schmidt Futures. In April 2023, Cytiva launched X-platform bioreactors to simplify upstream bioprocessing operations with single-use products. Initially, bioreactors were available in 50 L and 200 L sizes. The X-Platform bioreactors are equipped with Figurate automation solution software, and they can increase process efficiency through ergonomic improvements, production capacity, and simplified supply chain operations.

The growth of the biopharmaceutical sector, mainly due to technological advancements, increasing flexibility, and low operational costs, also benefits the upstream bioprocessing market in the US. As per the International Trade Administration (ITA), the US is the largest market for biopharmaceuticals and the global leader in biopharmaceutical R&D. According to the Pharmaceutical Research and Manufacturers Association (PhRMA), companies in the US account for nearly 50% of the global pharmaceutical R&D work, and they have succeeded in developing many novel medicines for which they hold intellectual property rights. A continuous increase in the development of new biologics, resulting in the approval of more new molecular entities (NME) by regulatory authorities, creates opportunities for the growth of the upstream bioprocessing market in the US. According to the Chemical & Engineering News, the US Food and Drug Administration (FDA) approved ~37, 50, and 53 new NMEs in 2022, 2021, and 2020, respectively.

Furthermore, Increasing R&D investments by US-based pharmaceutical and biotechnology companies to improve outcomes of clinical trials and ensure patient safety contributes to the growth of the upstream bioprocessing market in the US. In addition, growing traction toward precision medicine with rising investments by the US government will likely contribute to market growth in the coming years.

A few of the major primary and secondary sources referred to while preparing the report on the upstream bioprocessing market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization).

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the upstream bioprocessing market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global upstream bioprocessing market, thereby allowing players across the value chain to develop effective long-term strategies.  
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the upstream bioprocessing market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Upstream Bioprocessing Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Upstream Bioprocessing Market - Key Market Dynamics

  • 5.1 Upstream Bioprocessing Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Commercial Use of Single-Use Bioreactors
    • 5.2.2 Outsourcing of Biopharmaceutical Manufacturing
    • 5.2.3 Rapid Growth of Pharmaceutical and Biotechnology Industries
  • 5.3 Market Restraints
    • 5.3.1 Stringent Regulatory Framework
  • 5.4 Market Opportunities
    • 5.4.1 Technological Advancements
  • 5.5 Future Trends
    • 5.5.1 Increasing Investments in R&D in Biopharmaceutical Industry
  • 5.6 Impact of Drivers and Restraints:

6. Upstream Bioprocessing Market - Global Market Analysis

7. Upstream Bioprocessing Market Analysis - by Product Type

  • 7.1 Bioreactors/Fermenters
    • 7.1.1 Overview
    • 7.1.2 Bioreactors/Fermenters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Cell Culture
    • 7.2.1 Overview
    • 7.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Filters
    • 7.3.1 Overview
    • 7.3.2 Filters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Bags and Containers
    • 7.4.1 Overview
    • 7.4.2 Bags and Containers: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

8. Upstream Bioprocessing Market Analysis - by Workflow

  • 8.1 Media Preparation
    • 8.1.1 Overview
    • 8.1.2 Media Preparation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Cell Culture
    • 8.2.1 Overview
    • 8.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Cell Separation
    • 8.3.1 Overview
    • 8.3.2 Cell Separation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

9. Upstream Bioprocessing Market Analysis - by Usage Type

  • 9.1 Single-use
    • 9.1.1 Overview
    • 9.1.2 Single-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Multi-use
    • 9.2.1 Overview
    • 9.2.2 Multi-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

10. Upstream Bioprocessing Market Analysis - by Mode

  • 10.1 In-house
    • 10.1.1 Overview
    • 10.1.2 In-house: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.2 Outsourced
    • 10.2.1 Overview
    • 10.2.2 Outsourced: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

11. Upstream Bioprocessing Market - Geographical Analysis

  • 11.1 Overview
  • 11.2 North America
    • 11.2.1 North America Upstream Bioprocessing Market Overview
    • 11.2.2 North America: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.2.2.1 North America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Product Type
      • 11.2.2.2 North America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Workflow
      • 11.2.2.3 North America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Usage Type
      • 11.2.2.4 North America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Mode
    • 11.2.3 North America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.2.3.1 North America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.2.3.2 US
      • 11.2.3.3 US: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.3.3.1 US: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.2.3.3.2 US: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.2.3.3.3 US: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.2.3.3.4 US: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.2.3.4 Canada
      • 11.2.3.5 Canada: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.3.5.1 Canada: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.2.3.5.2 Canada: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.2.3.5.3 Canada: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.2.3.5.4 Canada: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.2.3.6 Mexico
      • 11.2.3.7 Mexico: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.3.7.1 Mexico: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.2.3.7.2 Mexico: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.2.3.7.3 Mexico: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.2.3.7.4 Mexico: Upstream Bioprocessing Market Breakdown, by Mode
  • 11.3 Europe
    • 11.3.1 Overview
    • 11.3.2 Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.3.2.1 Europe: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Product Type
      • 11.3.2.2 Europe: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Workflow
      • 11.3.2.3 Europe: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Usage Type
      • 11.3.2.4 Europe: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Mode
    • 11.3.3 Europe: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.3.3.1 Europe: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.3.3.2 UK
      • 11.3.3.3 UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.3.1 UK: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.3.3.3.2 UK: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.3.3.3.3 UK: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.3.3.3.4 UK: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.3.3.4 Germany
      • 11.3.3.5 Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.5.1 Germany: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.3.3.5.2 Germany: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.3.3.5.3 Germany: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.3.3.5.4 Germany: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.3.3.6 France
      • 11.3.3.7 France: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.7.1 France: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.3.3.7.2 France: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.3.3.7.3 France: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.3.3.7.4 France: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.3.3.8 Italy
      • 11.3.3.9 Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.9.1 Italy: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.3.3.9.2 Italy: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.3.3.9.3 Italy: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.3.3.9.4 Italy: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.3.3.10 Spain
      • 11.3.3.11 Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.11.1 Spain: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.3.3.11.2 Spain: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.3.3.11.3 Spain: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.3.3.11.4 Spain: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.3.3.12 Rest of Europe
      • 11.3.3.13 Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.13.1 Rest of Europe: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.3.3.13.2 Rest of Europe: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.3.3.13.3 Rest of Europe: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.3.3.13.4 Rest of Europe: Upstream Bioprocessing Market Breakdown, by Mode
  • 11.4 Asia Pacific
    • 11.4.1 Overview
    • 11.4.2 Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.4.2.1 Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Product Type
      • 11.4.2.2 Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Workflow
      • 11.4.2.3 Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Usage Type
      • 11.4.2.4 Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Mode
    • 11.4.3 Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.4.3.1 Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.4.3.2 China
      • 11.4.3.3 China: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.3.1 China: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.4.3.3.2 China: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.4.3.3.3 China: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.4.3.3.4 China: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.4.3.4 Japan
      • 11.4.3.5 Japan: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.5.1 Japan: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.4.3.5.2 Japan: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.4.3.5.3 Japan: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.4.3.5.4 Japan: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.4.3.6 India
      • 11.4.3.7 India: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.7.1 India: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.4.3.7.2 India: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.4.3.7.3 India: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.4.3.7.4 India: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.4.3.8 Australia
      • 11.4.3.9 Australia: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.9.1 Australia: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.4.3.9.2 Australia: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.4.3.9.3 Australia: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.4.3.9.4 Australia: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.4.3.10 South Korea
      • 11.4.3.11 South Korea: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.11.1 South Korea: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.4.3.11.2 South Korea: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.4.3.11.3 South Korea: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.4.3.11.4 South Korea: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.4.3.12 Rest of APAC
      • 11.4.3.13 Rest of APAC: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.13.1 Rest of APAC: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.4.3.13.2 Rest of APAC: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.4.3.13.3 Rest of APAC: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.4.3.13.4 Rest of APAC: Upstream Bioprocessing Market Breakdown, by Mode
  • 11.5 Middle East and Africa
    • 11.5.1 Overview
    • 11.5.2 Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.5.2.1 Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Product Type
      • 11.5.2.2 Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Workflow
      • 11.5.2.3 Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Usage Type
      • 11.5.2.4 Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Mode
    • 11.5.3 Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.5.3.1 Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.5.3.2 South Africa
      • 11.5.3.3 South Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.3.3.1 South Africa: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.5.3.3.2 South Africa: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.5.3.3.3 South Africa: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.5.3.3.4 South Africa: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.5.3.4 Saudi Arabia
      • 11.5.3.5 Saudi Arabia: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.3.5.1 Saudi Arabia: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.5.3.5.2 Saudi Arabia: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.5.3.5.3 Saudi Arabia: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.5.3.5.4 Saudi Arabia: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.5.3.6 UAE
      • 11.5.3.7 UAE: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.3.7.1 UAE: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.5.3.7.2 UAE: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.5.3.7.3 UAE: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.5.3.7.4 UAE: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.5.3.8 Rest of Middle East and Africa
      • 11.5.3.9 Rest of Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.3.9.1 Rest of Middle East and Africa: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.5.3.9.2 Rest of Middle East and Africa: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.5.3.9.3 Rest of Middle East and Africa: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.5.3.9.4 Rest of Middle East and Africa: Upstream Bioprocessing Market Breakdown, by Mode
  • 11.6 South and Central America
    • 11.6.1 Overview
    • 11.6.2 South and Central America: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.6.2.1 South and Central America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Product Type
      • 11.6.2.2 South and Central America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Workflow
      • 11.6.2.3 South and Central America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Usage Type
      • 11.6.2.4 South and Central America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Mode
    • 11.6.3 South and Central America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.6.3.1 South and Central America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.6.3.2 Brazil
      • 11.6.3.3 Brazil: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.6.3.3.1 Brazil: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.6.3.3.2 Brazil: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.6.3.3.3 Brazil: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.6.3.3.4 Brazil: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.6.3.4 Argentina
      • 11.6.3.5 Argentina: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.6.3.5.1 Argentina: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.6.3.5.2 Argentina: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.6.3.5.3 Argentina: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.6.3.5.4 Argentina: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.6.3.6 Rest of South and Central America
      • 11.6.3.7 Rest of South and Central America: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.6.3.7.1 Rest of South and Central America: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.6.3.7.2 Rest of South and Central America: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.6.3.7.3 Rest of South and Central America: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.6.3.7.4 Rest of South and Central America: Upstream Bioprocessing Market Breakdown, by Mode

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Upstream Bioprocessing Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Thermo Fisher Scientific Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Esco Micro Pte Ltd
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Cellexus International Ltd
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Sartorius AG
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Danaher Corp
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Getinge AB
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Merck KGaA
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Corning Inc
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Entegris Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 PBS Biotech Inc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Upstream Bioprocessing Market Segmentation
  • Table 2. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 3. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 4. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 5. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 6. North America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 7. North America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 8. North America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 9. North America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 10. North America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 11. US: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 12. US: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 13. US: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 14. US: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 15. Canada: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 16. Canada: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 17. Canada: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 18. Canada: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 19. Mexico: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 20. Mexico: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 21. Mexico: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 22. Mexico: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 23. Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 24. Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 25. Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 26. Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 27. Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 28. UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 29. UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 30. UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 31. UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 32. Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 33. Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 34. Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 35. Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 36. France: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 37. France: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 38. France: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 39. France: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 40. Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 41. Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 42. Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 43. Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 44. Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 45. Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 46. Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 47. Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 48. Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 49. Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 50. Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 51. Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 52. Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 53. Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 54. Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 55. Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 56. Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 57. China: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 58. China: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 59. China: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 60. China: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 61. Japan: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 62. Japan: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 63. Japan: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 64. Japan: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 65. India: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 66. India: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 67. India: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 68. India: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 69. Australia: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 70. Australia: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 71. Australia: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 72. Australia: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 73. South Korea: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 74. South Korea: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 75. South Korea: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 76. South Korea: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 77. Rest of APAC: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 78. Rest of APAC: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 79. Rest of APAC: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 80. Rest of APAC: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 81. Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 82. Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 83. Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 84. Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 85. Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 86. South Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 87. South Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 88. South Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 89. South Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 90. Saudi Arabia: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 91. Saudi Arabia: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 92. Saudi Arabia: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 93. Saudi Arabia: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 94. UAE: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 95. UAE: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 96. UAE: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 97. UAE: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 98. Rest of Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 99. Rest of Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 100. Rest of Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 101. Rest of Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 102. South and Central America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 103. South and Central America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 104. South and Central America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 105. South and Central America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 106. South and Central America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 107. Brazil: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 108. Brazil: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 109. Brazil: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 110. Brazil: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 111. Argentina: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 112. Argentina: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 113. Argentina: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 114. Argentina: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 115. Rest of South and Central America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 116. Rest of South and Central America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 117. Rest of South and Central America: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 118. Rest of South and Central America: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 119. Recent Organic Growth Strategies in Upstream Bioprocessing Market
  • Table 120. Recent Inorganic Growth Strategies in the Breast Cancer Therapeutics Market
  • Table 121. Glossary of Terms, Upstream Bioprocessing Market

List Of Figures

  • Figure 1. Upstream Bioprocessing Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Upstream Bioprocessing Market Breakdown, by Geography, 2022 and 2030 (%)
  • Figure 5. Upstream Bioprocessing Market Share (%) - by Product Type (2022 and 2030)
  • Figure 6. Bioreactors/Fermenters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Filters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Bags and Containers: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Others: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Upstream Bioprocessing Market Share (%) - by Workflow (2022 and 2030)
  • Figure 12. Media Preparation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Cell Separation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Upstream Bioprocessing Market Share (%) - by Usage Type (2022 and 2030)
  • Figure 16. Single-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Multi-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Upstream Bioprocessing Market Share (%) - by Mode (2022 and 2030)
  • Figure 19. In-house: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Outsourced: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Upstream Bioprocessing Market Breakdown by Region, 2022 and 2030 (%)
  • Figure 22. North America Upstream Bioprocessing Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 23. North America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 24. North America: Upstream Bioprocessing Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 25. US: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 26. Canada: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 27. Mexico: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 28. Europe: Upstream Bioprocessing Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 29. Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 30. Europe: Upstream Bioprocessing Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 31. UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 32. Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 33. France: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 34. Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 35. Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 36. Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 37. Asia Pacific: Upstream Bioprocessing Market, by Key Country - Revenue (2022) (US$ Thousands)
  • Figure 38. Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 39. Asia Pacific: Upstream Bioprocessing Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 40. China: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 41. Japan: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 42. India: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 43. Australia: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 44. South Korea: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 45. Rest of APAC: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 46. Middle East & Africa: Upstream Bioprocessing Market, by Key Country - Revenue (2022) (US$ Thousands)
  • Figure 47. Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 48. Middle East and Africa: Upstream Bioprocessing Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 49. South Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 50. Saudi Arabia: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 51. UAE: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 52. Rest of Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 53. South and Central America: Upstream Bioprocessing Market, by Key Country - Revenue (2022) (US$ Thousands)
  • Figure 54. South and Central America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 55. South and Central America: Upstream Bioprocessing Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 56. Brazil: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 57. Argentina: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 58. Rest of South and Central America: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 59. Growth Strategies in Upstream Bioprocessing Market